PROVID ANNOUNCES DISCOVERY COLLABORATION WITH IMMUNE CONTROL

Provid Pharmaceuticals of North Brunswick, N.J., has entered into a collaborative research agreement with Immune Control of West Conshohocken, Pa., for the development of lead compounds for diseases with immunological causes. Provid will employ its expertise in structure-based design, peptide mimetics technology, and medicinal chemistry to develop the lead compounds.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20380820&full=1)